WIKIMEDIA COMMONS, AYENA
As the death toll mounts among patients taking cardiac medications in Pakistan, government officials there have taken steps to stem the fatalities. Details coming out of Lahore, a metropolis at the epicenter of the trouble, are still sketchy, but dozens of patients have reportedly died from taking what are suspected to be heavy metal-laced heart drugs, and thousands more may be at risk. BBC News put the number of dead at 36, citing Pakistani officials, while news sources in the country are reporting anywhere from 27 to 72 deaths.
On Monday (January 23) Pakistan's Federal Investigation Agency arrested the owners of two local pharmaceutical companies that were supplying at least four different cardiac drugs—Cardiovestin (simvastatin), Alfagril (clopidogrel), Concort (amlodipine) and Soloprin (aspirin), according to NewsPakistan—to ...
